logo
  

Textron To Buy Electric Aircraft Maker Pipistrel For Undisclosed Terms

Textron Inc. (TXT), a multi-industry company owning Cessna, Beechcraft, and Bell aviation brands, announced Thursday that it has entered into an agreement to purchase electrically powered aircraft maker Pipistrel, based in Slovenia and Italy. The financial terms of the deal were not disclosed.

The transaction is expected to close during the second quarter of 2022, subject to customary closing conditions, including regulatory approvals.

Upon closing of the deal, Textron plans to form a new business segment, Textron eAviation, focused on the development of sustainable aircraft, which will include Pipistrel.

In 2020, Pipistrel's Velis Electro became the world's first, and currently only, electric aircraft to receive full-type European Aviation Safety Agency or EASA certification.

Textron expects Pipistrel to have access to greater resources, technical and regulatory expertise and a global aircraft sales and support network, enabling it to accelerate its development and certification of electric and hybrid electric aircraft.

Following the deal, Pipistrel founder and CEO Ivo Boscarol will remain a minority shareholder as well as Chairman Emeritus, consulting on future product plans and strategies for a two-year period.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
MTD Products Inc. is recalling 1,774 units of walk-behind self-propelled lawn mowers for potential risk of fire hazard, a statement by the U.S. Consumer Product Safety Commission (CPSC) showed. The company said the lawn mower can leak fuel when it is stored in the upright (vertical) storage position to pose a fire hazard. Nike Inc. announced its plans to exit the Russian market completely following Russia's ongoing war against Ukraine, reports said. The sportswear major, with more than 100 stores in the country, had suspended operations there in March. Earlier in March, while suspending operations temporarily, the company had said its customers that it couldn't guarantee product shipments. The U.S. Food and Drug Administration unveiled its action plan to advance drug development for rare neurodegenerative diseases, including Amyotrophic Lateral Sclerosis or ALS, in five years. The FDA plans specific actions such as regulatory science initiatives, enhancements to existing programs and new policy initiatives for the purpose. It will use public-private partnerships...
Follow RTT